SCHEMBL12637239

SCHEMBL12637239

O=C(O)c1ccc(COc2cc(OCc3ccc(C(=O)O)cc3)cc(-c3cc(-c4cc(OCc5ccc(C(=O)O)cc5)cc(OCc5ccc(C(=O)O)cc5)c4)cc(-c4cc(OCc5ccc(C(=O)O)cc5)cc(OCc5ccc(C(=O)O)cc5)c4)c3)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
NR4A2 P43354 4/20 0.62
NR4A1 P22736 1/20 0.62
NR4A3 Q92570 1/20 0.62
RXRA P19793 7/20 0.61
RXRB P28702 7/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
POLB P06746 1/20 0.61
RXRG P48443 2/20 0.59
TSHR P16473 1/20 0.59
SRD5A2 P31213 2/20 0.57
PLA2G4B P0C869 2/20 0.54
PTPRC P08575 1/20 0.53
PTPN2 P17706 1/20 0.53
PTPN1 P18031 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14536502 0.93 MEN1 (0.73) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL13383911 0.92 RXRA (0.57) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL16321477 0.89 MEN1 (0.73) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL18687040 0.86 MEN1 (0.74) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL8134318 0.83 NR4A2 (0.85) NR4A2NR4A1NR4A3RXRARXRB
SCHEMBL14190789 0.82 RXRA (0.60) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL31141980 0.82 MEN1 (0.79) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL29185186 0.81 NR4A2 (0.60) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL14217923 0.81 RXRB (0.52) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL14511354 0.81 NR4A2 (0.59) MEN1KMT2ANR4A2NR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947423-B2 Photosensitive compound and photoresist composition including the same DONGJIN SEMICHEM CO., LTD. (KR) 2011-05-24 US disclosed
US-7947423-B2 Photosensitive compound and photoresist composition including the same DONGJIN SEMICHEM CO., LTD. (KR) 2011-05-24 US disclosed
US-7695893-B2 Photo-sensitive compound and photoresist composition including the same DONGJIN SEMICHEM CO., LTD. (KR) 2010-04-13 US disclosed
US-7695893-B2 Photo-sensitive compound and photoresist composition including the same DONGJIN SEMICHEM CO., LTD. (KR) 2010-04-13 US disclosed
US-20090081587-A1 PHOTOSENSITIVE COMPOUND AND PHOTORESIST COMPOSITION INCLUDING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2009-03-26 US disclosed
US-20090081587-A1 PHOTOSENSITIVE COMPOUND AND PHOTORESIST COMPOSITION INCLUDING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2009-03-26 US disclosed
US-20080305430-A1 PHOTO-SENSITIVE COMPOUND AND PHOTORESIST COMPOSITION INCLUDING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2008-12-11 US disclosed
US-20080305430-A1 PHOTO-SENSITIVE COMPOUND AND PHOTORESIST COMPOSITION INCLUDING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305430-A1 PHOTO-SENSITIVE COMPOUND AND PHOTORESIST COMPOSITION INCLUDING THE SAME CRY1, CRY2, CYP1A1 MEN1 1423/4885KMT2A 1560/4885NR4A2 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.